Albemarle (NYSE:ALB) reported Q4 EPS of $8.62, $0.36 better than the analyst estimate of $8.26. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.62 billion.
GUIDANCE:
Albemarle sees FY2023 revenue of $11.3-12.9 billion, versus the consensus of $11.17 billion. Sees adjusted EBITDA of $4.2 - $5.1 billion.